Medications

Review paper compares two leading pancreatic cancer drugs

An in-depth analysis of two common treatments for advanced pancreatic cancer from The University of Toledo has found the combination chemotherapy drug Folfirinox is more likely to promote progression-free survival—a notable ...

Oncology & Cancer

Treating stomach cancer

More than 26,000 people in the U.S. will be diagnosed with stomach cancer this year, and nearly 11,000 people will die of the disease, according to the American Cancer Society. Stomach cancer accounts for about 1.5% of all ...

Oncology & Cancer

Doctors may not be giving young cancer patients what they need

The rate of cancer deaths in the U.S. has steadily declined for several decades. But there's a caveat: We've recently seen a small but worrisome increase in the rate of certain cancers—particularly colon cancers—among ...

Oncology & Cancer

Strategies to shield breast cancer patients from lymphedema

In a global effort to improve the lives of breast cancer survivors, new health research has looked at strategies that can help prevent lymphedema for millions of cancer survivors as a result of damage or removal of their ...

page 10 from 40